Cellmid Limited (CDY:ASX) Investor Relations Material

Overview

Cellmid Limited, an Australian consumer health company, has been making waves in the anti-aging industry around the world. The company develops, manufactures, and markets products related to hair, skin, and wellbeing in various countries including the US, China, and Japan. Their innovative products include FGF5 inhibitor hair health and hair growth products sold under various brand names like evolis, Jo-Ju RED, and Lexilis BLACK. The company sells its products through a range of channels that include retailers, wholesalers, and a direct-to-consumer, e-commerce platform. Cellmid Limited was founded in 2004 and is headquartered in Sydney, Australia.

Frequently Asked Questions

What is Cellmid Limited's ticker?

Cellmid Limited's ticker is CDY

What exchange is Cellmid Limited traded on?

The company's shares trade on the ASX stock exchange

Where are Cellmid Limited's headquarters?

They are based in Sydney, Australia

How many employees does Cellmid Limited have?

There are 11-50 employees working at Cellmid Limited

What is Cellmid Limited's website?

It is https://cellmid.com.au/

What type of sector is Cellmid Limited?

Cellmid Limited is in the Healthcare sector

What type of industry is Cellmid Limited?

Cellmid Limited is in the Biotechnology industry

Who are Cellmid Limited's peers and competitors?

The following five companies are Cellmid Limited's industry peers:

- Pfenex Inc

- Abeona Therapeutics

- Akcea Therapeutics, Inc.

- Brickell Biotech, Inc.

- Caladrus Biosciences